Ceribell inc CBLL.US 總覽分析
CBLL 投資分析
看多重點:
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足,尚無法提供評分
CBLL 近期報酬表現
-0.86%
Ceribell inc
1.99%
同產業平均
-0.64%
S&P500
與 CBLL 同產業的標的表現
- QTRX Quanterix corp價值 4 分趨勢 2 分波段 4 分籌碼 3 分股利 1 分查看更多
CBLL 公司資訊
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient's EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient's EEG data.